I know there's the NICE guidance, and then what a CCG will pay for, and what the cancer drugs fund will pay for. But those decisions almost always are about cost-effective, and not just cost.
I know there's the NICE guidance, and then what a CCG will pay for, and what the cancer drugs fund will pay for. But those decisions almost always are about cost-effective, and not just cost.